Under construction – not a live service

Skip to content

Frontlight Research

Ankylosing spondylitis trials in South Korea

In South Korea 6 Also abroad 89

6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Where
Seoul
Age
18 years to 80 years
People
315 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07133633 · EU 2025-521059-21-00
No phaseTaking people
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
Where
Busan, Gwangju, Jinju
Age
18 years to 40 years
People
70
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06905288
No phaseTaking people
Korean Post-marketing Surveillance for Xeljanz XR
Where
Seoul
Age
18 years and over
People
200
Run by
Pfizer
See details and how to joinNCT04876781
No phaseTaking people
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Where
Seoul
Age
10 years and over
People
500
Run by
Seoul National University Hospital
See details and how to joinNCT07011979
No phaseTaking people
Korean College of Rheumatology Biologics and Targeted Therapy Registry
Where
Seoul
Age
18 years and over
People
10,000
Run by
Seoul National University Hospital
See details and how to joinNCT01965132
No phaseTaking people
Multi-omics Database for Integrative Microbiome Analysis in a Cohort of Korean Patients With Ankylosing Spondylitis
Where
Seoul
Age
19 years to 60 years
People
600
Run by
Tae-Hwan Kim
See details and how to joinNCT06076083

Under construction, not live – Ankylosing spondylitis trials in South Korea – Frontlight Research